Significant Shift in UPC Pharma Patent Litigation: Sanofi’s Recent Actions
Sanofi’s recent infringement lawsuits at the Unified Patent Court (UPC) mark a pivotal moment for
June 17, 2024
Join the Webinars on Latest Legal Updates Hosted by Legal Experts.
Latest Webinars
Legal Updates
Partners Mishcon De Reya Webinar Date: 29th February, 2024 | Timings: 4:30 PM IST Agenda To explore the historical rationale underlying the concept...
Add to Wishlist
Free
Legal Updates
Partners: Bird & Bird The webinar series bring together leading legal experts who will share the latest legal updates, decisions, and insights ...
Add to Wishlist
₹3,000
Legal Updates
Partners: Lakshmikumaran & Sridharan The webinar series bring together leading legal experts who will share the latest legal updates, decisions...
Add to Wishlist
₹3,000
Legal Updates
Partners: Sai Krishna & Associates Agenda: The speakers will explore: 1. Designing divisional applications a. Recent judgements on whether appl...
Add to Wishlist
₹3,000
About Us
iPEssentia is a boutique Intellectual Property firm with freshly brewed enthusiasm, empowered by decades of experience in building & leading the in-house Intellectual Property functions of multinational companies.
Our Mission
Lead change in Intellectual Property services and enable businesses to enhance their business performance.
Our Vision
Provide businesses with innovative intellectual property solutions & services to unleash their intellectual property potential.
OUR SERVICES AND CAPABILITIES
A complete IP Life-cycle services ranging from IP landscape to ranging from IP management.
Blog
FTC Backs Amneal on Unlawful Orange Book Listings
Update: Teva Granted 30-Day Stay on Inhaler Patents’ Orange Book Delisting Last week, a federal
June 16, 2024
Novartis vs. Pharmathen: Octreotide
Sandostatin (Octreotide) LAR is used for treating acromegaly, carcinoid tumors, and neuroendocrine tumors, among other
June 11, 2024
Important Update on SPC Regulation Interpretation!
In a recent decision, the Swedish Patent and Market Court provided critical insights into the
May 7, 2024